[Hyperbaric oxygen and antianginal agents: experimental and clinical aspects of their interaction].
Efuni
S N
SN
Seriakov
V V
VV
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy* / Q000378:metabolism / Q000628:therapy; D000818:Animals; D003131:Combined Modality Therapy; D005609:Free Radicals; D006801:Humans; D006931:Hyperbaric Oxygenation; D015227:Lipid Peroxidation; D009206:Myocardium / Q000378:metabolism; D005996:Nitroglycerin / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D051381:Rats; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D005609:Free Radicals; D011433:Propranolol; D014700:Verapamil; D005996:Nitroglycerin